HCID 89588561, compound → HCID 89588814, compound
Reaction equation
[CH2:1]([O:8][C:9]1[C:15]2[CH:16]=[C:17]([F:20])[CH:18]=[CH:19][C:14]=2[O:13][CH:12]=[C:11]([C:21]2[CH:26]=[CH:25][C:24]([Br:27])=[CH:23][CH:22]=2)[N:10]=1)[C:2]1[CH:7]=[CH:6][CH:5]=[CH:4][CH:3]=1>C(O)(C)C>[CH2:1]([O:8][C:9]1[C:15]2[C:14](=[CH:19][CH:18]=[C:17]([F:20])[CH:16]=2)[C:12]([OH:13])=[C:11]([C:21]2[CH:26]=[CH:25][C:24]([Br:27])=[CH:23][CH:22]=2)[N:10]=1)[C:2]1[CH:3]=[CH:4][CH:5]=[CH:6][CH:7]=1Participants
3
Reactant 1
Product 1
Reagents, catalysts & solvents 1
Conditions
- Temperature
- 140 °C
Procedure
5-Benzyloxy-3-(4-bromo-phenyl)-7-fluoro-benzo[f][1,4]oxazepine (830 mg, 1.96 mmol) was dissolved in isopropanol, degassed under reduced pressure and purged with argon. The reaction mixture was heated at 140° C. under microwave irradiation for 1 h. The solvent was then evaporated to dryness to afford the title compound as a solid, which was used without any further purification (750 mg, 90% yield).
Workup
- customdegassed under reduced pressure
- custompurged with argon
- customThe solvent was then evaporated to dryness
Sources & evidence
- ORD record
- ord-5276394176e64a4887cf04b0fc65086e
- Source dataset
- uspto-grants-2016_08
- Patent number
- US09422243B2
Reaction notes
Loading…